The case for insulin treatment early in type 2 diabetes
Pasquale J. Palumbo, MD
Mayo Clinic Scottsdale, Scottsdale, AZ
Address: Pasquale J. Palumbo, MD, Mayo Clinic Scottsdale, 13400 East Shea Boulevard, Scottsdale, AZ 85259; e-mail email@example.com
The preparation of this manuscript was supported in part by an unrestricted educational grant from Aventis Pharmaceuticals. This article discusses therapies that are not yet approved by the US Food and Drug Administration for the use under discusion.
ABSTRACTMost patients with type 2 diabetes ultimately need insulin therapy. This paper presents the case for starting insulin therapy sooner rather than later, preferably without oral drugs and in a "basal/bolus" regimen consisting of a daily dose of a long-acting insulin for basal coverage plus preprandial doses of a short-acting insulin.